Skip to main
ACHC
ACHC logo

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 26 analyst ratings
Buy
Strong Buy 38%
Buy 38%
Hold 23%
Sell 0%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc shows a robust outlook due to strong demand in the behavioral health sector, which has resulted in impressive organic growth through bed expansions and strategic de novo development. The company's operational improvements at underperforming facilities, alongside projected increases in state-directed Medicaid payments, suggest potential for enhanced earnings and overall financial performance. Additionally, Acadia's long-term growth targets indicate expectations of 7-9% revenue growth and 8-10% EBITDA growth from 2024 to 2028, further reinforcing a positive financial trajectory.

Bears say

Acadia Healthcare Co Inc is experiencing a significant negative outlook primarily due to persistent volume softness, leading to a projected FY25 EBITDA that could fall 10% below current estimates, along with a contraction in the enterprise multiple to 6.0x. The company's long-term targets indicate a decrease in the EBITDA margin from 22.5% in 2024 to 21.7% by 2028, raising concerns about its profitability trajectory. Recent guidance was disappointing, with a weaker-than-expected forecast for 2025 and a revised multi-year outlook that reflects a concerning reset in intermediate-term margin expectations, contributing to a 25% decline in stock value.

Acadia Healthcare (ACHC) has been analyzed by 26 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 38% recommend Buy, 23% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 26 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $61.10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $61.10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.